Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
co-development
Press Release
Sep 15, 2020
Triple Ring Technologies Announces Addition of Greg Kovacs, MD, PhD as Chief Medical Officer
Read More
Press Release
Aug 20, 2015
Axelar and Cadila Pharmaceuticals Announce Co-Development Agreement for Non-Small Cell Lung Cancer Treatment
Axelar AB and Cadila Pharmaceuticals Sweden AB have entered into a co-development agreement for further formulation development and clinical development of AXL1717 in patients with non-small cell lung cancer. Cadila Pharma will co-invest a proportion of the projected costs for the formulation development and clinical trials.
Read More
First
Prev
1
Next
Last